Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page
- Check5 days agoChange DetectedThe study record dates were updated, with new timestamps added (2026-05-22 and 2026-05-19) and older ones removed (2026-05-18 and 2026-04-24). These changes represent administrative updates to the trial record rather than modifications to the study content.SummaryDifference0.1%

- Check12 days agoChange DetectedA new revision 3.5.4 is added with recent date stamps (2026-05-18, 2026-04-24, 2026-04) and the note 'up to approximately 8 months'; older revision 3.5.3 and earlier dates/notes (2025-07-29, 2025-07-16, 'Minimum up to 6 months', 2025-07) were removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows a newer ClinicalTrials.gov site revision (v3.5.3 instead of v3.5.0) in the footer, indicating an update to the site software rather than the underlying study record.SummaryDifference0.0%

- Check69 days agoChange DetectedReplaced Napoli, Italy, 80131 with Naples, Italy, 80131 in the locations list. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check84 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No changes to study data, eligibility criteria, or outcomes are included.SummaryDifference0.0%

- Check105 days agoChange DetectedRevision v3.4.2 was added and Revision v3.4.1 was removed; these are minor metadata/versioning updates with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.